(Q37644575)

21 August 2017

title

Increased prevalence of obesity and glucose intolerance in youth treated with second-generation antipsychotic medications (English)

1 reference

21 August 2017

0 references

0 references

1 reference

1 reference

Constadina Panagiotopoulos

series ordinal

1

1 reference

21 August 2017

Rebecca Ronsley

series ordinal

2

1 reference

21 August 2017

Jana Davidson

series ordinal

3

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

Canadian Journal of Psychiatry

21 August 2017

published in

1 reference

21 August 2017

volume

54

1 reference

21 August 2017

issue

11

1 reference

21 August 2017

page(s)

743-749

1 reference

Survey of atypical antipsychotic prescribing by Canadian child psychiatrists and developmental pediatricians for patients aged under 18 years.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Bodyweight gain with atypical antipsychotics. A comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

The effects of antipsychotic therapy on serum lipids: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: a cross-sectional assessment of a primary health care database

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Atypical antipsychotic agents, retinopathy, nephropathy, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Metabolic side effects of atypical antipsychotics in children: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

The metabolic consequences of childhood obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

A retrospective analysis of the short-term effects of olanzapine and quetiapine on weight and body mass index in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Elevated total and central adiposity and low physical activity are associated with insulin resistance in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Diabetes, impaired fasting glucose, and elevated HbA1c in U.S. adolescents: the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Frequency of abnormal carbohydrate metabolism and diabetes in a population-based screening of adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Prevalence and trends of a metabolic syndrome phenotype among u.s. Adolescents, 1999-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Distribution of Lipoproteins by Age and Gender in Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

Atypical Antipsychotic Drugs and Hyperglycemia in Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370905401104

10.1177/070674370905401104

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference